What GLP-1s Do to Your Brain & Why Lion's Mane Matters Alongside Them
The side effect nobody warned you about, and the compound that addresses it directly.
The brain fog isn't in the leaflet. But it's in the forums.
Ask any GLP-1 user - Ozempic, Wegovy, Mounjaro, Zepbound, what nobody warned them about, and you'll get a similar answer. The weight loss works. The appetite suppression works. But somewhere in week three or four, the fog rolls in.
Slower processing. Words that don't surface. The sense of running cognitive tasks through treacle.
It's not in the official side effect list. It's all over Reddit, TikTok, and patient forums. And the mechanism is no longer a mystery.
Why GLP-1s affect the brain in the first place
GLP-1 receptor agonists don't just act on the gut. GLP-1 receptors are distributed throughout the central nervous system, including in the hypothalamus, the brainstem, and the brain's reward and memory pathways. That's how they suppress appetite. It's also why they affect cognition. NeuroReserve
The cognitive effects fall into two distinct buckets, and conflating them is where most coverage goes wrong.
The first bucket is indirect — and it's the bigger one
GLP-1 medications dramatically reduce calorie intake. The brain uses roughly 20% of the body's total energy. When food intake drops sharply, micronutrient density usually drops with it.
Vitamin B12, vitamin D, iron, B6, magnesium, zinc, selenium - these are the nutrients consistently flagged as deficient or trending toward deficiency in GLP-1 users. PubMed Central
Each one matters cognitively. B12 deficiency impairs the myelin sheath that insulates neural signals. B6 deficiency disrupts GABA and serotonin synthesis. Low vitamin D is independently associated with cognitive impairment.
The second bucket is muscle loss
GLP-1 driven weight loss includes a meaningful loss of lean muscle mass if protein intake isn't actively protected, a particular concern for women in perimenopause and menopause, who are already losing muscle to declining oestrogen and testosterone. Mayo Clinic
Less muscle means worse glucose handling, lower resting metabolism, and a steeper rebound risk if the medication is stopped.
The pattern is real. The pharma label doesn't capture it because it sits between pharmacology and nutrition. Outside the formal adverse event reporting categories, but inside almost every patient's lived experience.
What the cognitive symptoms actually look like
Across user reports and clinical practice notes, the cognitive picture on GLP-1s is consistent: brain fog, poor concentration, mental fatigue, and cognitive sluggishness, most prominent in the first 4 to 12 weeks of treatment, and again following dose increases. Drugs.com
Some users describe feeling "groggy and forgetful" or going "into a zombie state" for weeks at a time. Others report the opposite, improved clarity, likely from better blood sugar control and reduced inflammation. The variation isn't surprising. Cognitive outcomes on GLP-1s depend on diet quality, baseline nutrient status, sleep, and how aggressively the dose is titrated.
The point is not that GLP-1s damage the brain. The point is that they create the exact conditions, restricted intake, micronutrient strain, neurochemical adjustment under which targeted cognitive support is most useful.
Where Lion's Mane comes in
Lion's Mane (Hericium erinaceus) is one of the few natural compounds with a well-characterised mechanism for cognitive support. The active compounds, hericenones from the fruiting body and erinacines from the mycelium, stimulate the synthesis of Nerve Growth Factor (NGF), a protein essential for the survival, maintenance, and differentiation of neurons. PubMed Central
NGF matters because levels decline with age, and that decline is associated with the neuronal atrophy underlying cognitive ageing. Stimulating NGF production directly supports neuroplasticity, the brain's ability to form and strengthen new connections.
This isn't speculation. It's the most-studied mechanism in functional mushroom science.
The clinical evidence
The most cited human trial is Mori et al. (2009), published in Phytotherapy Research. Thirty Japanese adults aged 50–80 with mild cognitive impairment received either 3 g/day of Lion's Mane fruiting body powder or placebo for 16 weeks. The treatment group scored significantly higher on the Revised Hasegawa Dementia Scale at weeks 8, 12, and 16 compared to placebo. Four weeks after stopping, scores declined, supporting a causal relationship and indicating Lion's Mane is something you take consistently, not occasionally. Wiley
Saitsu et al. (2019) found similar cognitive improvements in healthy older adults taking 3.2 g/day for 12 weeks. A 2024 randomised controlled trial found significant cognitive improvement after 8 weeks of Lion's Mane supplementation, alongside changes in BDNF (brain-derived neurotrophic factor) and gut microbiota markers. A 2025 acute-effects trial in Frontiers in Nutrition showed measurable cognitive and mood effects in healthy younger adults from a single standardised fruiting body extract dose. Frontiers in Nutrition
The Alzheimer's Drug Discovery Foundation's review notes that effects in healthy populations are more modest than in those with measurable cognitive decline, which is honest framing. Lion's Mane is not a stimulant. It is not a fix. It is a neurotrophic support compound with weeks-to-months onset and a mechanism that compounds with consistent use.
Why this combination makes sense
Stack the two side by side.
GLP-1s reduce intake, which thins out the micronutrient base your brain runs on. They affect neurochemistry directly via central GLP-1 receptors. They risk muscle loss in a population - women over 40 - who can least afford it.
Lion's Mane supports NGF production, which underpins the neuroplasticity any brain under load, nutritional, hormonal, or pharmaceutical, needs more of, not less.
This isn't a Lion's Mane-cures-Ozempic-side-effects pitch. There's no trial of Lion's Mane in GLP-1 users specifically, yet. What there is: a clearly mapped problem (cognitive symptoms driven by nutrient strain and altered neurochemistry) and a compound with a clearly mapped mechanism (NGF support, demonstrated cognitive effects in older adults over 8–16 weeks).
For women in perimenopause or menopause taking a GLP-1, the case is even sharper. Oestrogen decline already destabilises cognition independently, verbal memory and executive function are first to feel it. Layer GLP-1-driven nutrient shifts on top, and you have two mechanisms compounding. Targeted neurotrophic support is one of the few levers that addresses both.
What to look for in a Lion's Mane product
Three things separate a useful Lion's Mane supplement from a cosmetic one.
Fruiting body, not mycelium-on-grain. Hericenones are concentrated in the fruiting body. Most cheap Lion's Mane supplements are mycelium grown on rice or oats, meaning the final product is largely starch from the growing substrate, with a fraction of the active compounds. Read the label. If it doesn't say fruiting body extract, assume it isn't.
A standardised, organic extract. A 1:8 or 8:1 extract ratio means what's in the capsule is concentrated, not raw powder. Organic certification rules out residual pesticides, relevant given mushrooms are bioaccumulators.
Third-party testing. The supplement industry is loosely regulated. Third-party assays for active compounds and contaminants are the only way to know what's actually in the bottle.
The bottom line
GLP-1s are reshaping how millions of people approach weight, blood sugar, and metabolic health. They work. They also create conditions, reduced intake, nutrient strain, central nervous system effects, under which cognition takes a hit, especially in the first three months and especially for women already navigating hormonal change.
Lion's Mane doesn't solve the underlying issue. Adequate protein, B12, vitamin D, and resistance training do that. But as a targeted neurotrophic support, backed by clinical trials in older adults, a clearly mapped mechanism, and a clean safety profile, it is one of the few supplements with a genuine case to make alongside GLP-1 therapy.
If you're on a GLP-1 and the fog has rolled in, that fog has reasons. Address the reasons. Then add what supports the brain through it.
What the brain actually needs
Lion's Mane, one of three organic fruiting body extracts in IMBG Clarity, is the most-studied neurotrophic compound in functional mushroom science. It supports the exact neural pathways that nutrient strain and hormonal shift disrupt. That's not coincidence. That's why it's in the formulation.
100% organic fruiting body. No mycelium filler. Biochemist-formulated for the brain under load - not a generic wellness blend.
Sources
- NeuroReserve (2025): How GLP-1 Affects the Brain, Part 1: What We Know So Far.
- PMC (2025): Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists. PMC12205620
- Mayo Clinic (2026): GLP-1 Medications and Muscle Loss: What to Know About Nutrition and Supplements.
- Drugs.com (2025): Does Ozempic cause brain fog?
- PMC (2023): Neurotrophic and Neuroprotective Effects of Hericium erinaceus. PMC10650066
- Mori, K., et al. (2009): Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research, 23(3), 367–372.
- Saitsu, Y., et al. (2019): Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomedical Research, 40(4), 125–131.
- Surendran, G., et al. (2025): Acute effects of a standardised extract of Hericium erinaceus on cognition and mood in healthy younger adults. Frontiers in Nutrition.
- Alzheimer's Drug Discovery Foundation: Lion's Mane & Your Brain — Cognitive Vitality.
- Kawagishi, H., et al. (1994): Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Letters.
